172 related articles for article (PubMed ID: 31408552)
1. Clinical efficacy of rituximab in the treatment of pemphigus vulgaris: A 10-year follow-up.
Laftah Z; Craythorne E; Mufti GJ; du Vivier A
J Oral Pathol Med; 2019 Oct; 48(9):861-862. PubMed ID: 31408552
[No Abstract] [Full Text] [Related]
2. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
Greenblatt DT; Benton EC; Groves RW; Setterfield JF
Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
[TBL] [Abstract][Full Text] [Related]
3. Clinical resolution of pemphigus vulgaris on rituximab.
Cusick E; Silverstein D
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Remissions in Recalcitrant Pemphigus Vulgaris.
Ahmed AR; Kaveri S; Spigelman Z
N Engl J Med; 2015 Dec; 373(27):2693-4. PubMed ID: 26716930
[No Abstract] [Full Text] [Related]
5. Rituximab Therapy for Childhood Pemphigus Vulgaris.
Kincaid L; Weinstein M
Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
[TBL] [Abstract][Full Text] [Related]
6. Complete remission after rituximab therapy in an HIV-positive patient with pemphigus vulgaris.
Polansky M; Patel N; Feldman R
Br J Dermatol; 2015 Dec; 173(6):1557-9. PubMed ID: 26122850
[No Abstract] [Full Text] [Related]
7. Pregnancy outcome after rituximab treatment before conception in patients affected by severe pemphigus vulgaris/superficialis.
Vassallo C; Grassi S; Tagliabue E; Piccolo A; Brazzelli V
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e331-e333. PubMed ID: 28079925
[No Abstract] [Full Text] [Related]
8. Nasal, pharyngeal, and laryngeal pemphigus vulgaris successfully treated with rituximab.
Sami N
Ear Nose Throat J; 2017; 96(4-5):E35-E38. PubMed ID: 28489243
[TBL] [Abstract][Full Text] [Related]
9. Long-term remission with rituximab therapy in a five-year-old patient with pemphigus vulgaris.
Erdoğan B; Meral EN; Topkarci Z; Hatipoğlu N; Kavak A
J Dtsch Dermatol Ges; 2024 Feb; 22(2):292-294. PubMed ID: 38009460
[No Abstract] [Full Text] [Related]
10. Resolution of a case of pediatric pemphigus vulgaris treated with rituximab.
Didona D; Paolino G; Donati M; Caposeina D; Calvieri S; Didona B
Acta Dermatovenerol Croat; 2014; 22(4):288-90. PubMed ID: 25580789
[TBL] [Abstract][Full Text] [Related]
11. Superiority of Rituximab Over Mycophenolate Mofetil in the Treatment of Pemphigus Vulgaris: A Step Further in Its Approval as a First-Line Treatment?
Lemieux A; Saber M; Côté B
J Cutan Med Surg; 2022; 26(1):103-104. PubMed ID: 34320862
[No Abstract] [Full Text] [Related]
12. Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris.
Bhattacharjee R; De D; Handa S; Minz RW; Saikia B; Joshi N
Dermatology; 2016; 232(5):572-577. PubMed ID: 27576321
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.
Uzun S; Bilgiç Temel A; Akman Karakaş A; Ergün E; Özkesici B; Eskiocak AH; Erat A; Uğurlu N; Nazlım B; Koç S; Bozkurt S; Dicle Ö; Alpsoy E; Yılmaz E
Int J Dermatol; 2016 Dec; 55(12):1362-1368. PubMed ID: 27653507
[TBL] [Abstract][Full Text] [Related]
14. RF-Rituximab: Revolutionizing the Treatment of Pemphigus.
Morgado-Carrasco D; Giavedoni P; Fustà-Novell X; Iranzo P
Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):177-178. PubMed ID: 28802491
[No Abstract] [Full Text] [Related]
15. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
[TBL] [Abstract][Full Text] [Related]
16. Rituximab treatment of pemphigus foliaceus: A retrospective study of 12 patients.
Palacios-Álvarez I; Riquelme-Mc Loughlin C; Curto-Barredo L; Iranzo P; García-Díez I; España A
J Am Acad Dermatol; 2021 Aug; 85(2):484-486. PubMed ID: 29894702
[No Abstract] [Full Text] [Related]
17. Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab.
Santiago-Vázquez M; González-Molina VJ; Rodriguez-Ramos FM; Colón-Fontanez F; Carrasquillo OY
Clin Pediatr (Phila); 2023 Jun; 62(6):541-547. PubMed ID: 36447375
[No Abstract] [Full Text] [Related]
18. [Treatment of severe refractory pemphigus vulgaris with rituximab].
Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
[TBL] [Abstract][Full Text] [Related]
19. Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.
Vinay K; Cazzaniga S; Amber KT; Feldmeyer L; Naldi L; Borradori L
J Am Acad Dermatol; 2018 Apr; 78(4):806-808. PubMed ID: 29146127
[No Abstract] [Full Text] [Related]
20. Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?
Aryanian Z; Balighi K; Emadi SN; Hatami P
J Cosmet Dermatol; 2024 Feb; 23(2):406-408. PubMed ID: 37916650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
